#Sweden #Gothenburg #Zinzino #XION #Omega-3

Zinzino and Xion International Group Join Forces for Algae Production

In a significant move aimed at enhancing its nutritional product line, Zinzino AB (PUBL.) has embarked on negotiations to acquire a 35% stake in Xion International Group, headquartered in Andorra. This strategic partnership is set to pave the way for the joint development of algae-based nutritional solutions, focusing specifically on producing omega-3 oil and spirulina utilizing innovative bioreactor technology.

Expanding Horizons through Joint Ventures

Zinzino recognizes the growing global demand for sustainable health products and aims to address this need by establishing a joint venture with Xion. The company has plans to leverage Xion's cutting-edge photobioreactor systems, which are among the first in the world for producing nutrient-rich microalgae. These sophisticated systems embody a natural cultivation method that emphasizes sustainability and efficiency, setting a new benchmark in algal production while reducing environmental impact.

The collaboration will not only secure a steady supply of raw materials for Zinzino's flagship product, BalanceOil+, but will also allow for greater brand protection and the enhancement of its proprietary technologies. Currently, Xion's operations are on a modest scale, generating approximately EUR 1.3 million, with a significant portion of production committed to Zinzino’s existing portfolio of spirulina-infused products, including those acquired through the Xelliss merger in 2024.

A Vision for Sustainable Growth

In an era marked by the urgency of sustainable practices, Zinzino’s CEO Dag Bergheim Pettersen emphasized the importance of securing vital resources without raising their carbon footprint. He stated, "Fish oil is a finite resource. Through our collaboration with Xion, we are securing a sustainable raw material for our nutritional supplements."

Looking ahead, Zinzino and Xion aim to establish a new entity named PhytoFerm, dedicated to producing omega-3 and various oils from algae through advanced bioreactor technology. This initiative reflects Zinzino's commitment to positioning itself as a leader in the sustainable nutritional supplement industry while responding to the rising consumer demand for clean, efficient, and environmentally friendly products.

Innovation at the Forefront

This partnership capitalizes on both companies’ strengths, merging Zinzino’s rich history in personal health solutions with Xion’s groundbreaking algae production methodologies. Xion's founder, Tino Bacchetta, believes that this venture, which integrates high-tech photobioreactors with evolutionary fermentation processes, could redefine the standards for nutritional supplements. Bacchetta remarks, "PhytoFerm is poised to lead the market in producing clean and nutrient-dense oils that cater to the health-conscious consumer."

Future Prospects

As Zinzino continues to explore avenues for sustainable growth and innovation, this co-ownership venture with Xion marks the continuation of its expansion strategy following several major acquisitions over recent years, including VMA Life, Enhanzz, Xelliss, and ACN. Through these strategic investments, Zinzino is amplifying its distribution capabilities while keeping an eye on diversifying into new markets and securing a solid foundation for future growth.

The finalization of the acquisition agreement for Xion is expected in the second half of 2025, further solidifying Zinzino’s mission to act not just as a health supplement provider but as a pioneer in fostering sustainable growth in the nutritional sector. With innovative ideas at the helm, both companies are set to embark on a journey that emphasizes health, sustainability, and a commitment to the well-being of their consumers and the planet alike.